MUMBAI, India, Nov. 3, 2025 /PRNewswire/ — Leading stainless steel manufacturer Viraj Profiles Pvt. Ltd. has organised a free eye check-up camp for students of a Zilha Parishad School in Boisar, Maharashtra, in collaboration with Ojas Maxivision Eye Hospitals Pvt. Ltd. and the Smt. Naliniben Chaganlal Dedhia Foundation.
As part of its CSR commitment to child health and community development, the initiative screened over 200 students, providing expert consultations and early diagnosis of vision-related issues. Children requiring further medical attention were guided for follow-up treatment, ensuring long-term care.
Mr. Neeraj Kochhar, Chairman, from Viraj Profiles said, “Good vision is essential to a child’s learning and confidence. Through this initiative, we want to ensure that every child gets the right care and a clear view of a bright future.”
Viraj Profiles continues to drive impactful CSR programs focused on healthcare, education, and community well-being, reinforcing its philosophy that real strength lies not only in steel but in the communities it serves.
About Viraj Profiles Pvt. Ltd.
Headquartered in Mumbai, Viraj Profiles is among the world’s largest stainless-steel exporters, supplying to over 90 countries and known for its strong commitment to innovation, sustainability, and social responsibility.
Logo: https://mma.prnewswire.com/media/2811576/Viraj_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/viraj-profiles-organises-eye-check-up-camp-for-school-children-in-boisar-302602317.html
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…
New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…
AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…
February 06, 2026 17:17 ET | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…